Cannabis Use in Metabolic Dysfunction-Associated Steatotic Liver Disease
Our study highlights that patients with MASLD have a lower risk of developing liver-related events, but a higher risk of MI and stroke with concomitant CU. Clinical trials involving CU and monitoring of its effects are limited, and further research is needed to elucidate the mechanisms underlying these novel findings.
Authors
- Aalam Sohal (ORCID: https://orcid.org/0000-0001-8365-7240)
- Carol M. Singh
- Shreyans Doshi
- Anurag Singh (ORCID: https://orcid.org/0009-0003-6041-6606)
- Madhav Changela (ORCID: https://orcid.org/0009-0002-5943-3372)
- Mihir Shah
- Ruchir Paladiya
- Vikash Kumar
- Neil Parikh
Institutions
- Creighton University (US)
- Hartford Hospital (US)
- Interfaith Medical Center (US)
- Carolinas Medical Center (US)
- Centennial Medical Center (US)
- Dayanand Medical College & Hospital (IN)
- Wake Forest University (US)
- University of Oklahoma Health Sciences Center (US)
- UConn Health (US)
Publication Details
- Journal
- Journal of Clinical Gastroenterology
- Published
- 2025-12-26
- DOI
- https://doi.org/10.1097/mcg.0000000000002321
- Primary Topic
- Cannabis and Cannabinoid Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00